Studies have demonstrated that TP53INP1 may have an anti-inflammatory role because it can inhibit the nuclear factor-κ B (NF-κB) signaling pathway in patients with allergic rhinitis, but the specific mechanism is largely unknown (39). Here, TP53INP1 is linked to allergic rhinitis.